Completed PHASE3 INTERVENTIONAL 3-arm NCT02160548

Adding Nebulized Salbutamol to Intravenous Atropine and Oxygen in OP Poisoning (SalbutamolOP)

Effect of Adding Nebulized Salbutamol to Intravenous Atropine and Oxygen During Resuscitation of OP Pesticide Poisoned Patients

Sponsor: Sylhet M.A.G.Osmani Medical College

Conditions Organophosphate Poisoning

Interventions Standard care Standard care+ 2.5 mg Salbutamol Standard care+ 5 mg Salbutamol

Updated 5 times since 2017 Last updated: Dec 28, 2015 Started: Apr 30, 2015 Primary completion: Dec 31, 2015 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02160548, this PHASE3 trial focuses on Organophosphate Poisoning and remains completed. Sponsored by Sylhet M.A.G.Osmani Medical College, it has been updated 5 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Apr 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sylhet M.A.G.Osmani Medical College
University of Edinburgh

Data source: Sylhet M.A.G.Osmani Medical College

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Sylhet, Bangladesh